| Mechanism | Example | Adverse Effects |
|---|---|---|
| Direct relaxation of smooth muscle | Nitric Oxide | Toxicity from production of NO2 and methemoglobin |
| Prostocyclin receptor stimulation | Iloprost | Systemic vascular effects |
| Prostocyclin receptor stimulation | Epoprostenol | Flushing and hypotension |
| Calcium channel blocker | Nifedipine | Hypotension |
| Endothelin receptor blocker | Bosentan | Liver dysfunction |
| Phosphodiesterase-5 inhibitor | Sildenafil | Few |
| Angiotensin receptor blocker | Ramipril | Hypotension |
| Pressure | Definition | Notes |
|---|---|---|
| Peak airway pressure | Maximum value of the airway pressure at airway opening | Influenced by airway resistance and lung/chest wall compliance. Increased with airway obstruction or decreased complaince issues |
| Plateau pressure | Pressure that is recorded within the airway when there is NO airflow (static compliance) | Only increases with worsening compliance. Good indicator of alveolar pressure. Obstruction has no effect (because no airflow) |
| Mean airway pressure | Average airway pressure over the total ventilatory cycle | This pressure affects heart-lung interactions |
| Drug | Mechanism | Effect on SSEPs |
|---|---|---|
| Ketamine | NMDA blocker (N-methyl-D-aspartate) | Increases |
| Dexmedetomidine | alpha-2 agonist | Decreases |
| Propofol | Enhances GABA-induced chloride current / GABA agonist | Decreases |
| Xenon | NMDA blocker (N-methyl-D-aspartate) | Decreases |
| Nitrous Oxide | NMDA blocker (N-methyl-D-aspartate) | Decreases |
| Tissue Area | Hormone Released | Example | Function |
|---|---|---|---|
| Zona glomerulosa | Mineralocorticoids | Aldosterone | Regulates mineral balance (Na retention) |
| Zona fasciculata | Glucocorticoids | Cortisol, Cortisone | Regulates glucose metabolism |
| Zona reticularis | Androgens | Dehydroepiandrosterone | Stimulates masculinization |
| Adrenal medulla | Stress hormones | Epi, Norepi | Stimulates sympathetic ANS |
-0, 1, 2 to each of the following:
| Drug Class | Examples | Notes |
|---|---|---|
| Calcium channel blockers | Nifedipine | most commonly used, causes hypotention |
| Cyclooxygenase inhibitors | Indomethacin, ketorolac | inhibits synthesis of prostaglandins from arachidonic acid |
| Beta-adrenergic receptor agonist | Terbutaline | selective for B2, pulmonary edema most serious adverse effect |
| Magnesium sulfate | Magnesium | Extracellular Mg competes with Ca at motor endplate |